SILVER SPRING, Md., Sept. 5, 2024 /PRNewswire/ -- September is National Food Safety Education Month. The U.S. Food and Drug Administration…
REHOVOT, Israel, Sept. 5, 2024 /PRNewswire/ -- Sequentify has partnered with Dexter, a Romanian distributor, to bring Sequentify's InfiniSeq™ library…
The companies share how their collaboration enables clinical trial enrollment for a novel cancer therapy for oncogene amplified cancers in…
DETROIT, Sept. 5, 2024 /PRNewswire/ -- The American Cancer Society announced a new event today, "Taste of Hope Detroit," an…
Halifax, Nova Scotia--(Newsfile Corp. - September 5, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona")…
Outgoing CEO, Chris Bunka, to remain on as Chairman of the Board of Directors and Executive Strategic Advisor KELOWNA, BC…
Company's Canalevia®-CA1 prescription drug is FDA conditionally approved for treatment of chemotherapy-induced diarrhea (CID) in dogs and is the first…
ATLANTA, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet…
NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage…
PITTSBURGH, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics,…